Jubilant Ingrevia Limited (BOM: 543271)

India flag India · Delayed Price · Currency is INR
708.75
-3.35 (-0.47%)
At close: Jan 20, 2025
48.10%
Market Cap 111.92B
Revenue (ttm) 41.10B
Net Income (ttm) 1.76B
Shares Out n/a
EPS (ttm) 11.09
PE Ratio 63.76
Forward PE n/a
Dividend 5.00 (0.70%)
Ex-Dividend Date Aug 2, 2024
Volume 13,945
Average Volume 33,421
Open 713.00
Previous Close 712.10
Day's Range 696.10 - 715.45
52-Week Range 421.60 - 884.95
Beta n/a
RSI 35.82
Earnings Date Jan 28, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal... [Read more]

Industry Chemicals and Allied Products
Founded 2019
Employees 2,283
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543271
Full Company Profile

Financial Performance

In 2023, Jubilant Ingrevia's revenue was 41.36 billion, a decrease of -13.34% compared to the previous year's 47.73 billion. Earnings were 1.83 billion, a decrease of -40.52%.

Financial Statements

News

There is no news available yet.